Table 3 Aetiological diagnosis in NCAP and CAP control group patients according to macrolide containing regimens and non-macrolide regimens
From: Lung inflammatory pattern and antibiotic treatment in pneumonia
NCAP | CAP control | |||
|---|---|---|---|---|
Macrolide regimens | Non-macrolide regimens | Macrolide regimens | Non-macrolideregimens | |
(n 23) | (n 29) | (n 9) | (n 6) | |
Microorganisms | ||||
- Streptococcus pneumoniae | 5 (21.7) | 8(27.6) | 2(22.2) | 2(33.3) |
- Pseudomonas aeruginosa | 2(8.7) | 5(17.2) | 1(11.1) | 0 |
- Escherichia coli | 0 | 2(6.9) | 0 | 0 |
- Streptococcus spp | 1(4.3) | 1(3.4) | 0 | 0 |
- MRSA | 0 | 2(6.9) | 0 | 0 |
- Polymicrobial | 0 | 7(24.1) | 0 | 0 |
Pathogens isolated | 8(34.8) | 16(55.2) | 3(33.3) | 2(33.3) |